307 related articles for article (PubMed ID: 24533871)
21. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
[TBL] [Abstract][Full Text] [Related]
22. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
[TBL] [Abstract][Full Text] [Related]
24. Patient and tumor characteristics predictive of an elevated hepatopulmonary shunt fraction before radioembolization of hepatic tumors.
Yerubandi V; Ronald J; Howard BA; Suhocki PV; James OG; Wong TZ; Kim CY
Nucl Med Commun; 2016 Sep; 37(9):939-46. PubMed ID: 27104280
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
26. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
27. Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.
Lam MG; Goris ML; Iagaru AH; Mittra ES; Louie JD; Sze DY
J Nucl Med; 2013 Dec; 54(12):2055-61. PubMed ID: 24144563
[TBL] [Abstract][Full Text] [Related]
28. Same-day
Gabr A; Kallini JR; Gates VL; Hickey R; Kulik L; Desai K; Thornburg B; Marshall K; Salzig K; Williams M; Del Castillo C; Ganger D; Hohlastos E; Baker T; Lewandowski RJ; Salem R
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2353-2359. PubMed ID: 27315059
[TBL] [Abstract][Full Text] [Related]
29. Same-Day Repeat Hepatopulmonary Shunt Measurement during Planning Angiography for Hepatic Radioembolization.
McGregor H; Hill M; Kuo P; Woodhead G; Patel M
J Vasc Interv Radiol; 2020 Jul; 31(7):1069-1073. PubMed ID: 32439249
[TBL] [Abstract][Full Text] [Related]
30. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
Heusner TA; Hamami ME; Ertle J; Hahn S; Poeppel T; Hilgard P; Bockisch A; Forsting M; Antoch G
Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775
[TBL] [Abstract][Full Text] [Related]
31. Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
Elsayed M; Martin JG; Dabrowiecki A; Goldman DT; Faraj R; McMahon JT; Kokabi N; Duszak R; Newsome J; Bercu ZL
Nucl Med Commun; 2019 Nov; 40(11):1154-1157. PubMed ID: 31568192
[TBL] [Abstract][Full Text] [Related]
32. Elevated Lung Shunt Fraction as a Prognostic Indicator for Disease Progression and Metastasis in Hepatocellular Carcinoma.
Sandow T; DeVun D; Gulotta P; Bohorquez H; Kirsch D
J Vasc Interv Radiol; 2016 Jun; 27(6):804-11. PubMed ID: 27009570
[TBL] [Abstract][Full Text] [Related]
33. Association of dysmorphic intratumoral vessel with high lung shunt fraction in patients with hepatocellular carcinoma.
Choi TW; Joo I; Kim HC
Sci Rep; 2022 Aug; 12(1):14248. PubMed ID: 35989374
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of hepatopulmonary shunt obtained from pretherapy 99mTc MAA scintigraphy and post-therapy 90Y Bremsstrahlung imaging in 90Y microsphere therapy.
Jha AK; Zade AA; Rangarajan V; Purandare N; Shah SA; Agrawal A; Kulkarni SS; Shetty N
Nucl Med Commun; 2012 May; 33(5):486-90. PubMed ID: 22395029
[TBL] [Abstract][Full Text] [Related]
35. Organ-level internal dosimetry for intra-hepatic-arterial administration of
Kappadath SC; Lopez BP
Med Phys; 2022 Aug; 49(8):5504-5512. PubMed ID: 35612924
[TBL] [Abstract][Full Text] [Related]
36. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
[TBL] [Abstract][Full Text] [Related]
37. Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer.
Yu N; Srinivas SM; Difilippo FP; Shrikanthan S; Levitin A; McLennan G; Spain J; Xia P; Wilkinson A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):834-9. PubMed ID: 22871239
[TBL] [Abstract][Full Text] [Related]
38. Factors modulating
Lopez BP; Mahvash A; Long JP; Lam MGEH; Kappadath SC
J Appl Clin Med Phys; 2022 Dec; 23(12):e13734. PubMed ID: 35906892
[TBL] [Abstract][Full Text] [Related]
39. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
40. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
